Functional and connectivity changes during working memory inHuntington's disease: 18month longitudinal data from the IMAGE-HD study

Brain and Cognition

Volumn 83, Issue 1, 2013, Pages 80-91

  Georgiou Karistianis, Nellie ^a   Poudel, Govinda R ^a,b   Domínguez D, Juan F ^a   Langmaid, Rebecca ^a   Gray, Marcus A ^a,c   Churchyard, Andrew ^d   Chua, Phyllis ^a   Borowsky, Beth ^e   Egan, Gary F ^a,f,g   Stout, Julie C ^a  

^a MONASH UNIVERSITY   (Australia)

^b Life Sciences Computation Centre   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d MONASH MEDICAL CENTRE   (Australia)

^e CHDI MANAGEMENT CHDI FOUNDATION   (United States)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Functional connectivity; Functional MRI; Huntington's disease; Longitudinal; Working memory

Indexed keywords

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; BEHAVIOR; BRAIN FUNCTION; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; HUNTINGTON CHOREA; LONGITUDINAL STUDY; MALE; NEUROIMAGING; PREFRONTAL CORTEX; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PUTAMEN; RESPONSE TIME; VOXEL BASED MORPHOMETRY; WORKING MEMORY;

FUNCTIONAL CONNECTIVITY; FUNCTIONAL MRI; HUNTINGTON'S DISEASE; LONGITUDINAL; WORKING MEMORY;

ADULT; AGED; BRAIN MAPPING; FEMALE; HUMANS; HUNTINGTON DISEASE; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REACTION TIME; TIME FACTORS; YOUNG ADULT;

EID: 84882255988     PISSN: 02782626     EISSN: 10902147     Source Type: Journal    
DOI: 10.1016/j.bandc.2013.07.004     Document Type: Article

References (64)

1. Ashburner J., Friston K.J. Voxel-based morphometry-The methods. NeuroImage 2000, 11:805-821.
2. Ashburner J., Friston K.J. Unified segmentation. NeuroImage 2005, 26:839-851.
3. Aylward E.H. Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease. Brain Research Bulletin 2007, 72:152-158.
4. Aylward E.H., Nopoulos P.C., Ross C.A., Langbehn D.R., Pierson R.K., Mills J.A., et al. Longitudinal change in regional brain volumes in prodromal Huntington disease. Journal of Neurology, Neurosurgery and Psychiatry 2011, 82:405-410.
5. Beck A.T., Steer R.A., Brown G.K. Manual for the beck depression inventory-II 1996, Psychological Corporation, San Antonio.
6. Bohanna I., Georgiou-Karistianis N., Hannan A.J., Egan G.F. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Research Reviews 2008, 58:209-225.
7. Browne S.E., Beal M.F. Oxidative damage in Huntington's disease pathogenesis. Antioxidants & Redox Signaling 2006, 8:2061-2073.
8. Bullmore E., Sporns O. The economy of brain network organization. Nature Reviews Neuroscience 2012, 13:336-349.
9. Callicott J.H., Egan M.F., Mattay V.S., Bertolino A., Bone A.D., Verchinksi B., et al. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. American Journal of Psychiatry 2003, 160:709-719.
10. Doty R.L., Shaman P., Kimmelman C.P., Dann M.S. University of pennsylvania smell identification test: A rapid quantitative olfactory function test for the clinic. Laryngoscope 1984, 94:176-178.
11. Douaud G., Smith S., Jenkinson M., Behrens T., Johansen-Berg H., Vickers J., et al. Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain 2007, 130:2375-2386.
12. Feigin A., Ghilardi M.F., Huang C., Ma Y., Carbon M., Guttman M., et al. Preclinical Huntington's disease: Compensatory brain responses during learning. Annals of Neurology 2006, 59:53-59.
13. Feigin A., Leenders K.L., Moeller J.R., Missimer J., Kuenig G., Spetsieris P., et al. Metabolic network abnormalities in early Huntington's disease: An [18F]FDG PET study. Journal of Nuclear Medicine 2001, 42:1591-1595.
14. Feigin A., Tang C., Ma Y., Mattis P., Zgaljardic D., Guttman M., et al. Thalamic metabolism and symptom onset in preclinical Huntington's disease. Brain 2007, 130:2858-2867.
15. Gavrilescu M., Stuart G.W., Rossell S., Henshall K., McKay C., Sergejew A.A., et al. Functional connectivity estimation in fMRI data: Influence of preprocessing and time course selection. Human Brain Mapping 2008, 29:1040-1052.
16. Georgiou-Karistianis N. A peek inside the Huntington's brain: Will functional imaging take us one step closer in solving the puzzle?. Experimental Neurology 2009, 220:5-8.
17. Georgiou-Karistianis N., Gray M.A., Domínguez D J.F., Dymowski A.R., Bohanna I., Johnston L.A., et al. Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: The IMAGE-HD study. Neurobiology of Disease 2013, 51:82-92.
18. Georgiou-Karistianis N., Scahill R., Tabrizi S.J., Squitieri F., Aylward E. Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials. Neurosci Biobehav Rev 2013, 37:480-490.
19. Georgiou-Karistianis N., Sritharan A., Farrow M., Cunnington R., Stout J., Bradshaw J., et al. Increased cortical recruitment in Huntington's disease using a Simon task. Neuropsychologia 2007, 45:1791-1800.
20. Georgiou-Karistianis, N., Stout, J.C., Domínguez D, J.F., Carron, S.P., Ando, A., Churchyard, A., et al. (2013). Functional magnetic resonance imaging of working memory in Huntington's disease: Cross-sectional data from the IMAGE-HD study. Human Brain Mapping. (in press).
21. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N.A., Friston K.J., Frackowiak R.S.J. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage 2001, 14:21-36.
22. Grace J., Mallory P.F. Frontal systems behavior scale: Professional manual 2001, Psychological Assessment Resources, Lutz.
23. Gray M.A., Egan G.F., Ando A., Churchyard A., Chua P., Stout J.C., et al. Prefrontal activity in Huntington's disease reflects cognitive and neuropsychiatric disturbances: The IMAGE-HD study. Experimental Neurology 2013, 239:218-228.
24. Hedges L.V., Olkin I. Nonparametric estimators of effect size in meta-analysis. Psychological Bulletin 1984, 96:573-580.
25. Hinton S.C., Paulsen J.S., Hoffmann R.G., Reynolds N.C., Zimbelman J.L., Rao S.M. Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches. Journal of the International Neuropsychological Society 2007, 13:539-543.
26. Hobbs N.Z., Henley S.M.D., Wild E.J., Leung K.K., Frost C., Barker R.A., et al. Automated quantification of caudate atrophy by local registration of serial MRI: Evaluation and application in Huntington's disease. NeuroImage 2009, 47:1659-1665.
27. Klöppel S., Draganski B., Golding C.V., Chu C., Nagy Z., Cook P.A., et al. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain 2008, 131:196-204.
28. Klöppel S., Draganski B., Siebner H.R., Tabrizi S.J., Weiller C., Frackowiak R.S.J. Functional compensation of motor function in pre-symptomatic Huntington's disease. Brain 2009, 132:1624-1632.
29. Langbehn D.R., Brinkman R.R., Falush D., Paulsen J.S., Hayden M.R. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clinical Genetics 2004, 65:267-277.
30. Lawrence A.D., Sahakian B.J., Hodges J.R., Rosser A.E., Lange K.W., Robbins T.W. Executive and mnemonic functions in early Huntington's disease. Brain 1996, 119:1633-1645.
31. Lemiere J., Decruyenaere M., Evers-Kiebooms G., Vandenbussche E., Dom R. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation: A longitudinal follow-up study. Journal of Neurology 2004, 251:935-942.
32. Lund T.E., Madsen K.H., Sidaros K., Luo W.L., Nichols T.E. Non-white noise in fMRI: Does modelling have an impact?. NeuroImage 2006, 29:54-66.
33. MacDonald M.E., Ambrose C.M., Duyao M.P., Myers R.H., Lin C., Srinidhi L., et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
34. Montoya A., Price B.H., Menear M., Lepage M. Brain imaging and cognitive dysfunctions in Huntington's disease. Journal of Psychiatry and Neuroscience 2006, 31:21-29.
35. Nelson H.E., Willison J., Owen A.M. National adult reading test. International Journal of Geriatric Psychiatry 1992, 7, 2nd ed.:533.
36. Oldfield R.C. The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
37. Paulsen J.S. Functional imaging in Huntington's disease. Experimental Neurology 2009, 216:272-277.
38. Paulsen J.S., Zimbelman J.L., Hinton S.C., Langbehn D.R., Leveroni C.L., Benjamin M.L., et al. FMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease. American Journal of Neuroradiology 2004, 25:1715-1721.
39. Penney J.B., Vonsattel J.P., MacDonald M.E., Gusella J.F., Myers R.H. CAG repeat number governs the development rate of pathology in Huntington's disease. Annals of Neurology 1997, 41:689-692.
40. Rosas H.D., Tuch D.S., Hevelone N.D., Zaleta A.K., Vangel M., Hersch S.M., et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures. Movement Disorders 2006, 21:1317-1325.
41. Roze E., Cahill E., Martin E., Bonnet C., Vanhoutte P., Betuing S., et al. Huntington's disease and striatal signaling. Frontiers in Neuroanatomy 2011, 6:1-16.
42. Seibert T.M., Majid D.S.A., Aron A.R., Corey-Bloom J., Brewer J.B. Stability of resting fMRI interregional correlations analyzed in subject-native space: A 1-year longitudinal study in healthy adults and premanifest Huntington's disease. NeuroImage 2012, 59:2452-2463.
43. Smith A. Symbol digit modality test (SDMT): Manual (revised) 1982, Psychological Services, Los Angeles.
44. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E.J., Johansen-Berg H., et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004, 23:S208-S219.
45. Sritharan A., Egan G.F., Johnston L., Horne M., Bradshaw J.L., Bohanna I., et al. A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease. Journal of Neurology, Neurosurgery and Psychiatry 2010, 81:257-262.
46. Stout J.C., Paulsen J.S., Queller S., Solomon A.C., Whitlock K.B., Campbell J.C., et al. Neurocognitive Signs in Prodromal Huntington Disease. Neuropsychology 2011, 25:1-14.
47. Stroop J.R. Studies of interference in serial verbal reactions. Journal of Experimental Psychology 1935, 18:643-662.
48. Tabrizi S.J., Langbehn D.R., Leavitt B.R., Roos R.A., Durr A., Craufurd D., et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. The Lancet Neurology 2009, 8:791-801.
49. Tabrizi S.J., Reilmann R., Roos R.A., Durr A., Leavitt B., Owen G., et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: Analysis of 24month observational data. The Lancet Neurology 2012, 11:42-53.
50. Tabrizi S.J., Scahill R.I., Durr A., Roos R.A., Leavitt B.R., Jones R., et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: The 12-month longitudinal analysis. The Lancet Neurology 2011, 10:31-42.
51. Thiruvady D.R., Georgiou-Karistianis N., Egan G.F., Ray S., Sritharan A., Farrow M., et al. Functional connectivity of the prefrontal cortex in Huntington's disease. Journal of Neurology, Neurosurgery and Psychiatry 2007, 78:127-133.
52. Unschuld P.G., Joel S.E., Liu X., Shanahan M., Margolis R.L., Biglan K.M., et al. Impaired cortico-striatal functional connectivity in prodromal Huntington's disease. Neuroscience Letters 2012, 514:204-209.
53. Watson D., Wu K.D. Development and validation of the schedule of compulsions, obsessions, and pathological impulses (SCOPI). Assessment 2005, 12:50-65.
54. Wolf R.C., Grön G., Sambataro F., Vasic N., Wolf N.D., Thomann P.A., et al. Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease. Journal of Cerebral Blood Flow and Metabolism 2011, 31:1908-1918.
55. Wolf R.C., Grön G., Sambataro F., Vasic N., Wolf N.D., Thomann P.A., et al. Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness. Human Brain Mapping 2012, 33:2161-2173.
56. Wolf R.C., Sambataro F., Vasic N., Schönfeldt-Lecuona C., Ecker D., Landwehrmeyer B. Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Experimental Neurology 2008, 213:137-144.
57. Wolf R.C., Sambataro F., Vasic N., Schönfeldt-Lecuona C., Ecker D., Landwehrmeyer B. Altered frontostriatal coupling in pre-manifest Huntington's disease: Effects of increasing cognitive load. European Journal of Neurology 2008, 15:1180-1190.
58. Wolf R.C., Sambataro F., Vasic N., Wolf N.D., Thomann P.A., Landwehrmeyer G.B., et al. Longitudinal functional magnetic resonance imaging of cognition in preclinical Huntington's disease. Experimental Neurology 2011, 231:214-222.
59. Wolf R.C., Vasic N., Carlos S.-L., Ecker D., Landwehrmeyer G.B. Cortical dysfunction in patients with Huntington's disease during working memory performance. Human Brain Mapping 2009, 30:327-339.
60. Wolf R.C., Vasic N., Schönfeldt-Lecuona C., Ecker D., Landwehrmeyer B.G. Functional imaging of cognitive processes in Huntington's disease and its presymptomatic mutation carriers. Nervenarzt 2008, 79:408-420.
61. Wolf R.C., Vasic N., Schönfeldt-Lecuona C., Landwehrmeyer G.B., Ecker D. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: Evidence from event-related fMRI. Brain 2007, 130:2845-2857.
62. Yu Z.X., Li S.H., Evans J., Pillarisetti A., Li H., Li X.J. Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease. J Neurosci 2003, 23:2193-2202.
63. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983, 67:361-370.
64. Zimbelman J.L., Paulsen J.S., Mikos A., Reynolds N.C., Hoffmann R.G., Rao S.M. FMRI detection of early neural dysfunction in preclinical Huntington's disease. Journal of the International Neuropsychological Society 2007, 13:758-769.